| case report | Q2782326 |
| scholarly article | Q13442814 |
| P50 | author | Hakon Hakonarson | Q30003940 |
| P2093 | author name string | Dong Li | |
| Kenneth E Thummel | |||
| Michael A Levine | |||
| Kevin E Meyers | |||
| Colin Patrick Hawkes | |||
| P2860 | cites work | Idiopathic hypercalcaemia in infants | Q73208515 |
| Idiopathic hypercalcaemia in infants with failure to thrive | Q73537397 | ||
| Impact of genetic polymorphism in relation to other factors on expression and function of human drug-metabolizing p450s | Q82289060 | ||
| Ketoconazole in Cushing's disease: is it worth a try? | Q87179331 | ||
| Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia | Q24634055 | ||
| An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway | Q30511948 | ||
| An official ATS statement: hepatotoxicity of antituberculosis therapy | Q34571651 | ||
| The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers | Q34583322 | ||
| Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry | Q35189519 | ||
| Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes | Q35608569 | ||
| Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy | Q35869662 | ||
| Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia | Q36721536 | ||
| 1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis | Q36733570 | ||
| Association of Mutations in SLC12A1 Encoding the NKCC2 Cotransporter With Neonatal Primary Hyperparathyroidism. | Q36911479 | ||
| Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. | Q37160635 | ||
| Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia | Q38320243 | ||
| Bioengineering anabolic vitamin D-25-hydroxylase activity into the human vitamin D catabolic enzyme, cytochrome P450 CYP24A1, by a V391L mutation | Q38672766 | ||
| A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis | Q41475312 | ||
| Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole. | Q42392666 | ||
| Osteomalacia in an HIV-infected man receiving rifabutin, a cytochrome P450 enzyme inducer: a case report | Q43058205 | ||
| Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment. | Q43098170 | ||
| Mutations in CYP24A1 and idiopathic infantile hypercalcemia | Q45345347 | ||
| Hepatotoxicity associated with antifungal therapy after bone marrow transplantation | Q46593130 | ||
| Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes | Q46686355 | ||
| Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia. | Q54149900 | ||
| Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents | Q64133863 | ||
| Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria | Q67602886 | ||
| Rifampicin-induced adrenal crisis in addisonian patients receiving corticosteroid replacement therapy | Q70648914 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin D | Q175621 |
| rifampicin | Q422652 | ||
| P304 | page(s) | 1440-1446 | |
| P577 | publication date | 2017-05-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations. | |
| P478 | volume | 102 |
| Q87828161 | CYP3A4 mutation causes vitamin D-dependent rickets type 3 |
| Q90374323 | Consensus statement from 2nd International Conference on Controversies in Vitamin D |
| Q57174194 | Drug-metabolizing enzymes CYP3A as a link between tacrolimus and vitamin D in renal transplant recipients: is it relevant in clinical practice? |
| Q64066212 | Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the Gene: A Case Report and Review of the Literature |
| Q92630903 | Nephrocalcinosis: A Review of Monogenic Causes and Insights They Provide into This Heterogeneous Condition |
| Q55030066 | Nephrolithiasis and Nephrocalcinosis in Childhood-Risk Factor-Related Current and Future Treatment Options. |
| Q64940667 | Three Sisters With Heterozygous Gene Variants of CYP24A1: Maternal Hypercalcemia, New-Onset Hypertension, and Neonatal Hypoglycemia. |
| Q57191698 | Vitamin D Toxicity-A Clinical Perspective |
Search more.